Literature DB >> 21416150

Translating DRiPs: progress in understanding viral and cellular sources of MHC class I peptide ligands.

Brian P Dolan1, Jack R Bennink, Jonathan W Yewdell.   

Abstract

It has been 15 years since we proposed the defective ribosomal product (DRiP) hypothesis to explain the rapid presentation of viral peptides by MHC class I molecules on the surface of infected cells. Here, we review the evidence for the contribution of DRiPs to antigen processing, pointing to the uncertainties regarding the physical nature of DRiPs, and emphasizing recent findings suggesting that peptide generation is a specialized process involving compartmentalized translation.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21416150      PMCID： PMC3393103          DOI： 10.1007/s00018-011-0656-z

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN： 1420-682X            Impact factor:   9.261


  95 in total

Review 1.  Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm.

Authors:  P E Wright; H J Dyson
Journal:  J Mol Biol       Date:  1999-10-22       Impact factor: 5.469

2.  Compartmentalized MHC class I antigen processing enhances immunosurveillance by circumventing the law of mass action.

Authors:  Avital Lev; Michael F Princiotta; Damian Zanker; Kazuyo Takeda; James S Gibbs; Chiharu Kumagai; Elizabeth Waffarn; Brian P Dolan; Anne Burgevin; Peter Van Endert; Weisan Chen; Jack R Bennink; Jonathan W Yewdell
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-29       Impact factor: 11.205

3.  RNA polymerase II inhibitors dissociate antigenic peptide generation from normal viral protein synthesis: a role for nuclear translation in defective ribosomal product synthesis?

Authors:  Brian P Dolan; Jonathan J Knowlton; Alexandre David; Jack R Bennink; Jonathan W Yewdell
Journal:  J Immunol       Date:  2010-11-03       Impact factor: 5.422

4.  Inactivation of peroxiredoxin I by phosphorylation allows localized H(2)O(2) accumulation for cell signaling.

Authors:  Hyun Ae Woo; Sun Hee Yim; Dong Hae Shin; Dongmin Kang; Dae-Yeul Yu; Sue Goo Rhee
Journal:  Cell       Date:  2010-02-19       Impact factor: 41.582

5.  Distinct pathways generate peptides from defective ribosomal products for CD8+ T cell immunosurveillance.

Authors:  Brian P Dolan; Lily Li; Charles A Veltri; Chris M Ireland; Jack R Bennink; Jonathan W Yewdell
Journal:  J Immunol       Date:  2011-01-12       Impact factor: 5.422

6.  Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decay.

Authors:  Fernando Pastor; Despina Kolonias; Paloma H Giangrande; Eli Gilboa
Journal:  Nature       Date:  2010-05-13       Impact factor: 49.962

7.  Isolation of mammalian 26S proteasomes and p97/VCP complexes using the ubiquitin-like domain from HHR23B reveals novel proteasome-associated proteins.

Authors:  Henrike C Besche; Wilhelm Haas; Steven P Gygi; Alfred L Goldberg
Journal:  Biochemistry       Date:  2009-03-24       Impact factor: 3.162

8.  Defective ribosomal products are the major source of antigenic peptides endogenously generated from influenza A virus neuraminidase.

Authors:  Brian P Dolan; Lily Li; Kazuyo Takeda; Jack R Bennink; Jonathan W Yewdell
Journal:  J Immunol       Date:  2009-12-28       Impact factor: 5.422

9.  Nuclear eukaryotic initiation factor 4E (eIF4E) colocalizes with splicing factors in speckles.

Authors:  J Dostie; F Lejbkowicz; N Sonenberg
Journal:  J Cell Biol       Date:  2000-01-24       Impact factor: 10.539

10.  The synthesis of truncated polypeptides for immune surveillance and viral evasion.

Authors:  Sylvain Cardinaud; Shelley R Starck; Piyanka Chandra; Nilabh Shastri
Journal:  PLoS One       Date:  2010-01-21       Impact factor: 3.240
View more
  32 in total

1.  MHC class I antigen processing distinguishes endogenous antigens based on their translation from cellular vs. viral mRNA.

Authors:  Brian P Dolan; Aditi A Sharma; James S Gibbs; Tshaka J Cunningham; Jack R Bennink; Jonathan W Yewdell
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-16       Impact factor: 11.205

2.  Enhanced Direct Major Histocompatibility Complex Class I Self-Antigen Presentation Induced by Chlamydia Infection.

Authors:  Erik D Cram; Ryan S Simmons; Amy L Palmer; William H Hildebrand; Daniel D Rockey; Brian P Dolan
Journal:  Infect Immun       Date:  2015-11-23       Impact factor: 3.441

3.  Impact of regulated secretion on antiparasitic CD8 T cell responses.

Authors:  Harshita Satija Grover; H Hamlet Chu; Felice D Kelly; Soo Jung Yang; Michael L Reese; Nicolas Blanchard; Federico Gonzalez; Shiao Wei Chan; John C Boothroyd; Nilabh Shastri; Ellen A Robey
Journal:  Cell Rep       Date:  2014-05-22       Impact factor: 9.423

4.  Major Histocompatibility Complex (MHC) Class I Processing of the NY-ESO-1 Antigen Is Regulated by Rpn10 and Rpn13 Proteins and Immunoproteasomes following Non-lysine Ubiquitination.

Authors:  Richard Golnik; Andrea Lehmann; Peter-Michael Kloetzel; Frédéric Ebstein
Journal:  J Biol Chem       Date:  2016-02-22       Impact factor: 5.157

Review 5.  Providing ligands for MHC class I molecules.

Authors:  Peter van Endert
Journal:  Cell Mol Life Sci       Date:  2011-03-02       Impact factor: 9.261

Review 6.  Re-examining class-I presentation and the DRiP hypothesis.

Authors:  Kenneth L Rock; Diego J Farfán-Arribas; Jeff D Colbert; Alfred L Goldberg
Journal:  Trends Immunol       Date:  2014-02-21       Impact factor: 16.687

7.  Using intein catalysis to probe the origin of major histocompatibility complex class I-presented peptides.

Authors:  Diego J Farfán-Arribas; Lawrence J Stern; Kenneth L Rock
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-01       Impact factor: 11.205

Review 8.  Natural killer cell responses during viral infections: flexibility and conditioning of innate immunity by experience.

Authors:  Silvia M Vidal; Salim I Khakoo; Christine A Biron
Journal:  Curr Opin Virol       Date:  2011-12       Impact factor: 7.090

9.  Enhanced Recognition of HIV-1 Cryptic Epitopes Restricted by HLA Class I Alleles Associated With a Favorable Clinical Outcome.

Authors:  Anju Bansal; Tiffanie Mann; Sarah Sterrett; Binghao J Peng; Anne Bet; Jonathan M Carlson; Paul A Goepfert
Journal:  J Acquir Immune Defic Syndr       Date:  2015-09-01       Impact factor: 3.731

10.  Immunodominant West Nile Virus T Cell Epitopes Are Fewer in Number and Fashionably Late.

Authors:  Saghar Kaabinejadian; Curtis P McMurtrey; Sojung Kim; Rinki Jain; Wilfried Bardet; Fredda B Schafer; Jason L Davenport; Aaron D Martin; Michael S Diamond; Jon A Weidanz; Ted H Hansen; William H Hildebrand
Journal:  J Immunol       Date:  2016-04-20       Impact factor: 5.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.